SPOTLIGHT: Quality control at Chinese heparin supplier

Curious how APP Pharmaceuticals' heparin supplier in China handles safety and quality control? Check out The Wall Street Journal's behind-the-scenes look at Shenzhen Hepalink Pharmaceutical. APP, remember, is supplying the lion's share of heparin in the U.S. in the wake of Baxter's big recall and production stoppage. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.